Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

High cell density cultivation of a recombinant E. coli strain expressing a key enzyme in bioengineered heparin production.

Restaino OF, Bhaskar U, Paul P, Li L, De Rosa M, Dordick JS, Linhardt RJ.

Appl Microbiol Biotechnol. 2013 May;97(9):3893-900. doi: 10.1007/s00253-012-4682-z. Epub 2013 Jan 15.

2.

High cell density cultivation of a recombinant Escherichia coli strain expressing a 6-O-sulfotransferase for the production of bioengineered heparin.

Zhang J, Suflita M, Fiaschetti CM, Li G, Li L, Zhang F, Dordick JS, Linhardt RJ.

J Appl Microbiol. 2015 Jan;118(1):92-8. doi: 10.1111/jam.12684. Epub 2014 Dec 2.

3.

High cell density cultivation of recombinant Escherichia coli strains expressing 2-O-sulfotransferase and C5-epimerase for the production of bioengineered heparin.

Zhang J, Suflita M, Li G, Zhong W, Li L, Dordick JS, Linhardt RJ, Zhang F.

Appl Biochem Biotechnol. 2015 Mar;175(6):2986-95. doi: 10.1007/s12010-014-1466-1. Epub 2015 Jan 14.

4.

Metabolic engineering of Escherichia coli BL21 for biosynthesis of heparosan, a bioengineered heparin precursor.

Zhang C, Liu L, Teng L, Chen J, Liu J, Li J, Du G, Chen J.

Metab Eng. 2012 Sep;14(5):521-7. doi: 10.1016/j.ymben.2012.06.005. Epub 2012 Jul 8.

PMID:
22781283
5.

Response surface optimization of the heparosan N-deacetylation in producing bioengineered heparin.

Wang Z, Li J, Cheong S, Bhaskar U, Akihiro O, Zhang F, Dordick JS, Linhardt RJ.

J Biotechnol. 2011 Dec 10;156(3):188-96. doi: 10.1016/j.jbiotec.2011.08.013. Epub 2011 Sep 10.

6.

E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor.

Wang Z, Ly M, Zhang F, Zhong W, Suen A, Hickey AM, Dordick JS, Linhardt RJ.

Biotechnol Bioeng. 2010 Dec 15;107(6):964-73. doi: 10.1002/bit.22898.

7.

Production of recombinant bacteriocin divercin V41 by high cell density Escherichia coli batch and fed-batch cultures.

Yildirim S, Konrad D, Calvez S, Drider D, Prévost H, Lacroix C.

Appl Microbiol Biotechnol. 2007 Dec;77(3):525-31. Epub 2007 Sep 19.

PMID:
17882416
8.

Recombinant Escherichia coli K5 strain with the deletion of waaR gene decreases the molecular weight of the heparosan capsular polysaccharide.

Huang H, Liu X, Lv S, Zhong W, Zhang F, Linhardt RJ.

Appl Microbiol Biotechnol. 2016 Sep;100(18):7877-85. doi: 10.1007/s00253-016-7511-y. Epub 2016 Apr 14.

PMID:
27079575
9.
10.

Effects of carbon sources and feeding strategies on heparosan production by Escherichia coli K5.

Liu Y, Liu L, Chen J, Li J, Du G, Chen J.

Bioprocess Biosyst Eng. 2012 Sep;35(7):1209-18. doi: 10.1007/s00449-012-0708-2. Epub 2012 Feb 26.

PMID:
22367530
11.

Escherichia coli K5 heparosan fermentation and improvement by genetic engineering.

Wang Z, Dordick JS, Linhardt RJ.

Bioeng Bugs. 2011 Jan-Feb;2(1):63-7. doi: 10.4161/bbug.2.1.14201.

12.

Control of the heparosan N-deacetylation leads to an improved bioengineered heparin.

Wang Z, Yang B, Zhang Z, Ly M, Takieddin M, Mousa S, Liu J, Dordick JS, Linhardt RJ.

Appl Microbiol Biotechnol. 2011 Jul;91(1):91-9. doi: 10.1007/s00253-011-3231-5. Epub 2011 Apr 12.

13.

Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode.

Borja GM, Meza Mora E, Barrón B, Gosset G, Ramírez OT, Lara AR.

Microb Cell Fact. 2012 Sep 19;11:132. doi: 10.1186/1475-2859-11-132.

14.
15.

Quantitation of heparosan with heparin lyase III and spectrophotometry.

Huang H, Zhao Y, Lv S, Zhong W, Zhang F, Linhardt RJ.

Anal Biochem. 2014 Feb 15;447:46-8. doi: 10.1016/j.ab.2013.10.029. Epub 2013 Oct 30.

PMID:
24184357
16.

Enhanced production of the nonribosomal peptide antibiotic valinomycin in Escherichia coli through small-scale high cell density fed-batch cultivation.

Li J, Jaitzig J, Hillig F, Süssmuth R, Neubauer P.

Appl Microbiol Biotechnol. 2014 Jan;98(2):591-601. doi: 10.1007/s00253-013-5309-8. Epub 2013 Oct 25.

PMID:
24419900
17.

Improvement of D-lactate productivity in recombinant Escherichia coli by coupling production with growth.

Zhou L, Tian KM, Niu DD, Shen W, Shi GY, Singh S, Wang ZX.

Biotechnol Lett. 2012 Jun;34(6):1123-30. doi: 10.1007/s10529-012-0883-x. Epub 2012 Feb 25.

PMID:
22367280
18.

[High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].

Zhang Y, Shen YL, Xia XX, Sun AY, Wei DZ, Zhou JS, Zhang GJ, Wang LH, Jiao BH.

Sheng Wu Gong Cheng Xue Bao. 2004 May;20(3):408-13. Chinese.

PMID:
15971615
19.

Effect of eliminase gene (elmA) deletion on heparosan production and shedding in Escherichia coli K5.

Hickey AM, Bhaskar U, Linhardt RJ, Dordick JS.

J Biotechnol. 2013 Jun 10;165(3-4):175-7. doi: 10.1016/j.jbiotec.2013.03.018. Epub 2013 Apr 11.

20.

Production of recombinant Chikungunya virus envelope 2 protein in Escherichia coli.

Tripathi NK, Priya R, Shrivastava A.

Appl Microbiol Biotechnol. 2014 Mar;98(6):2461-71. doi: 10.1007/s00253-013-5426-4. Epub 2013 Dec 13.

PMID:
24337252

Supplemental Content

Support Center